CD5L and COVID-19: However, radar plots revealed a clear decrease in the average abundance of several complement proteins in IVIG-treated patients compared to both COVID-19 controls and healthy donors, including C1RL, CFD, CD5L, C8G, and CFHR5 (Figure 5C, Table 2).